<?xml version="1.0" ?>
<document id="19eed2e91c17ea20e9cbda665e19fad13a948ecf">
  <chunk id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c0" text="Human Cytomegalovirus Encoded miR-US25-1-5p Attenuates CD147/EMMPRIN-Mediated Early Antiviral Response">
    <entity charOffset="84-102" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c0.e0" ontology_id="GO_0051607" text="Antiviral Response" type="gene_function"/>
  </chunk>
  <chunk id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1" text="Cellular receptor-mediated signaling pathways play critical roles during the initial immune response to Human Cytomegalovirus (HCMV) infection. However, the involvement of type-I transmembrane glycoprotein CD147/EMMPRIN (extracellular matrix metalloproteinase inducer) in the antiviral response to HCMV infection is still unknown. Here, we demonstrated the specific knockdown of CD147 significantly decreased HCMV-induced activation of NF-κB and Interferon-beta (IFN-β), which contribute to the cellular antiviral responses. Next, we confirmed that HCMV-encoded miR-US25-1-5p could target the 3 UTR (Untranslated Region) of CD147 mRNA, and thus facilitate HCMV lytic propagation at a low multiplicity of infection (MOI). The expression and secretion of Cyclophilin A (sCyPA), as a ligand for CD147 and a proinflammatory cytokine, were up-regulated in response to HCMV stimuli. Finally, we confirmed that CD147 mediated HCMV-triggered antiviral signaling via the sCyPA-CD147-ERK (extracellular regulated protein kinases)/NF-κB axis signaling pathway. These findings reveal an important HCMV mechanism for evading antiviral innate immunity through its encoded microRNA by targeting transmembrane glycoprotein CD147, and a potential cause of HCMV inflammatory disorders due to the secretion of proinflammatory cytokine CyPA.">
    <entity charOffset="27-36" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e0" ontology_id="GO_0023052" text="signaling" type="gene_function"/>
    <entity charOffset="85-100" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e1" ontology_id="GO_0006955" text="immune response" type="gene_function"/>
    <entity charOffset="179-192" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e2" ontology_id="GO_0016021" text="transmembrane" type="gene_function"/>
    <entity charOffset="221-234" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e3" ontology_id="GO_0005576" text="extracellular" type="gene_function"/>
    <entity charOffset="221-241" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e4" ontology_id="GO_0031012" text="extracellular matrix" type="gene_function"/>
    <entity charOffset="276-294" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e5" ontology_id="GO_0051607" text="antiviral response" type="gene_function"/>
    <entity charOffset="740-749" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e6" ontology_id="GO_0046903" text="secretion" type="gene_function"/>
    <entity charOffset="944-953" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e7" ontology_id="GO_0023052" text="signaling" type="gene_function"/>
    <entity charOffset="979-992" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e8" ontology_id="GO_0005576" text="extracellular" type="gene_function"/>
    <entity charOffset="1031-1040" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e9" ontology_id="GO_0023052" text="signaling" type="gene_function"/>
    <entity charOffset="1122-1137" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e10" ontology_id="GO_0045087" text="innate immunity" type="gene_function"/>
    <entity charOffset="1180-1193" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e11" ontology_id="GO_0016021" text="transmembrane" type="gene_function"/>
    <entity charOffset="1278-1287" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e12" ontology_id="GO_0046903" text="secretion" type="gene_function"/>
  </chunk>
</document>
